ArticlePloS one2025

Socazolimab combined with carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: A cost-effectiveness analysis in China.

Lian Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.